ARCHIVES

Clearinghouse Finds Three Chemicals Pose Risk Of Cncer to Humans; 38 More Will Go On Test

This article is from The Cancer Letter archive.

Vol. 03 No. 31 | August 5, 1977

Download PDF Visit The Full Archive

Related Articles

Senate Committee Passes Bill To Speed FDA Approval Of Follow-On Biologics.

June 29, 2007

Lilly Begins Phase III Trial Of Alimta In Extensive SCLC

October 27, 2006

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

December 26, 2014

Arimidex Continues To Show Improvement Over Tamoxifen

December 27, 2002

Research Needed On Hormonally Active Agents, Report Finds

August 6, 1999

Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal

December 16, 2011